A metaanalysis: efficacy of highflow nasal cannula oxygen therapy in adult patients with severe immunosuppression
Gan Wanling1, Xu Juling1, Yao Huiping2, Wen Huan1, Chen Yan1
2020, 35(2):
116-122.
doi:10.3969/j.issn.1004-583X.2020.02.004
Asbtract
(
445 )
PDF (1210KB)
(
139
)
HTML
Related Articles |
Metrics
Objective To systematically evaluate the efficacy of Highflow nasal cannula oxygen therapy(HFNC) in adult patients with severe immunosuppression.Methods Databases including PubMed, Embase, Cochrane Library, Ovid, EBSCO, WanFang, VIP, CNKI, CBM were searched by computer to collect the RCT studies about the efficacy of HFNC in adult patients with severe immunosuppression.The retrieval time limit was from the establishment of the database to May 2019. In order to avoid omission, the references included in the literature were searched manually. Revman 5.3 software was used for metaanalysis.Results A total of 8 studies involving 1 302 patients were included. Metaanalysis results showed that HFNC could reduce the intubation rate of patients compared with conventional oxygen therapy (OR=0.77, 95%CI [0.60, 0.97], Z=2.19, P=0.03), but there was no statistical difference in reducing intubation rate compared with noninvasive ventilation (OR=0.43, 95%CI[0.17, 1.08], Z=1.80, P=0.07). The results of two subcombinations showed that the intubation rate of severe immunosuppressive patients was significantly reduced by HFNC compared with control oxygen therapy (combination:OR=0.74, 95%CI[0.58, 0.93], Z=2.58, P=0.01), but there was no significant difference in reducing mortality, infection rate and shortening ICU hospitalization time (case fatality rate: OR=0.84, 95%CI[0.66, 1.08], Z=1.34, P=0.18, infection rate: OR=0.80, 95%CI[0.56, 1.15], Z=1.19, P=0.24, ICU hospitalization time: OR=0.19, 95%CI[-2.51, 2.12], Z=0.16, P=0.87).In sensitivity analysis HFNC could significantly reduce ICU hospitalization time compared with control oxygen therapy.Conclusion Compared with the control oxygen therapy, HFNC can significantly reduce the intubation rate of patients, but it can not reduce the mortality and infection rate of patients.